Inhibition of ATR leads to increased sensitivity to hypoxia/reoxygenation

Cancer Research
E M HammondA J Giaccia

Abstract

The transient opening and closing of tumor vasculature result in periods of severe oxygen deprivation (hypoxia) followed by reoxygenation. This exerts a positive selective pressure for cells that have lost their sensitivity to killing by reduced oxygen levels. These cells are effectively resistant to hypoxia-induced apoptosis and conventional therapeutic approaches. Here we show hypoxia-induced S-phase arrest results in regions of single-stranded DNA in stalled replication forks and signals the activation of ATR. S-phase cells represent the most sensitive phase of the cell cycle to the stress of hypoxia/reoxygenation. Loss of ATR or inhibition of ATR kinase activity results in a further loss of reproductive viability in S-phase cells when exposed to hypoxic conditions followed by reoxygenation but has little effect on the inhibition of DNA synthesis. This is, at least in part, mediated via Chk1 signaling because loss of Chk1 also results in increased sensitivity to hypoxia/reoxygenation. The observed decrease in reproductive survival is in part because of the accumulation of DNA damage in S-phase cells during hypoxia exposure in the absence of full ATR activity. Therefore, ATR acts to protect stalled replication forks during hy...Continue Reading

References

Jan 1, 1975·Mutation Research·J Timson
Aug 30, 1989·Biochemical and Biophysical Research Communications·H ProbstK Scheffler
Jan 1, 1993·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M HöckelP Vaupel
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·K A CimprichS L Schreiber
Jan 30, 1999·Genes & Development·R S TibbettsR T Abraham
Feb 13, 2001·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Y M LeeK W Kim
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·M B Kastan, D S Lim
Sep 7, 2001·Genes & Development·R T Abraham
Nov 21, 2001·Japanese Journal of Cancer Research : Gann·K SakanoS Kawanishi
Feb 28, 2002·Molecular and Cellular Biology·Ester M HammondAmato J Giaccia
Dec 24, 2002·Cancer Biology & Therapy·J Martin Brown
Jan 10, 2003·The Journal of Biological Chemistry·Ester M HammondAmato J Giaccia
Jan 16, 2003·Cell·Anne M CasperThomas W Glover
Mar 12, 2003·Genes & Development·Eric J Brown, David Baltimore
Mar 21, 2003·Current Biology : CB·Karlene A Cimprich
Apr 4, 2003·Genes & Development·Xin WangLei Li
May 29, 2003·Molecular Cell·José Antonio TerceroJohn F X Diffley
Jun 7, 2003·Science·Lee Zou, Stephen J Elledge
Dec 19, 2003·Genes & Development·Mikhail LomonosovAshok R Venkitaraman

❮ Previous
Next ❯

Citations

Dec 21, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·L Eric HuangAdrian L Harris
Apr 7, 2007·Cancer Metastasis Reviews·Ranjit S BindraPeter M Glazer
Apr 21, 2009·Nature Medicine·Matina EconomopoulouTriantafyllos Chavakis
Feb 8, 2008·Nature Reviews. Cancer·Thomas HelledayRicky A Sharma
May 25, 2011·Nature Reviews. Cancer·William R Wilson, Michael P Hay
Apr 25, 2012·Nature Reviews. Clinical Oncology·Annamaria Rapisarda, Giovanni Melillo
Jul 22, 2010·Molecular and Cellular Biology·Yunfu LinJohn H Wilson
Nov 5, 2008·Molecular and Cellular Biology·Zuzana BencokovaEster M Hammond
Jan 28, 2010·Cancer Research·Isabel M PiresEster M Hammond
Sep 30, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Monica OlcinaEster M Hammond
Sep 4, 2010·Cell Division·Mark Meuth
Dec 5, 2006·PLoS Pathogens·Joshua L AndersenVicente Planelles
Apr 1, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Thomas Helleday
Nov 21, 2007·Current Opinion in Cell Biology·Ester M HammondAmato J Giaccia
Jul 13, 2007·Trends in Biochemical Sciences·Sonia Rocha
Mar 31, 2007·International Journal of Radiation Oncology, Biology, Physics·Jennifer K ChenDennis F Deen
Oct 22, 2013·Genes, Chromosomes & Cancer·Rahul A ParikhSusanne M Gollin
Jun 17, 2016·Molecular & Cellular Oncology·Gwenola ManicIlio Vitale
Aug 9, 2005·Cancer Letters·Ester M HammondAmato J Giaccia
Jul 20, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Alice X MengRobert G Bristow
Mar 8, 2014·Clinical Oncology : a Journal of the Royal College of Radiologists·E M HammondK J Williams
May 10, 2015·DNA Repair·Susan E Scanlon, Peter M Glazer
May 26, 2015·DNA Repair·Isabella Marcomini, Susan M Gasser
Apr 16, 2013·Cancer Treatment Reviews·Emmanouil FokasRuth J Muschel
Dec 14, 2011·Cancer Letters·Benjamin P C ChenAroumougame Asaithamby
Mar 17, 2015·Frontiers in Genetics·Randi G SyljuåsenÅslaug Helland
May 4, 2005·Biochemical and Biophysical Research Communications·Ester M Hammond, Amato J Giaccia
Dec 31, 2017·The FEBS Journal·Natalie NgEster M Hammond
Jun 29, 2018·The Journal of Clinical Investigation·Frank P VendettiChristopher J Bakkenist
Jun 21, 2012·British Journal of Cancer·I M PiresE M Hammond
Aug 5, 2017·Journal of Experimental & Clinical Cancer Research : CR·Stephen Riffle, Rashmi S Hegde
Jan 29, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tong Zhang, Charles L Sentman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis